Abstract-Workers involved in the nuclear fuel cycle have a potential for internal exposure to uranium. The present review of epidemiological studies of these workers aims to elucidate the relationship between occupational internal uranium exposure and cancer risk. Eighteen cohort and 5 nested casecontrol studies published since 1980 are reviewed. Workers occupationally exposed to uranium appear to be at increased risk of mortality from neoplasms of the lung, larynx, and lymphatic and haematopoietic tissue. Currently available evidence for a positive association between internal exposure to uranium and the risk of cancer is limited. The common weaknesses in reviewed studies include low statistical power and inaccurate assessment of internal exposure to uranium. 
INTRODUCTION
A LARGE body of literature exists concerning the health effects of external radiation in the nuclear worker population (NRC 2005) . Recent epidemiological investigations (Cardis et al. 2005 (Cardis et al. , 2007 have provided direct evidence of health effects from protracted occupational exposure to low doses of external radiation, compatible with current radiation risk estimates based on populations with high dose rate acute exposures (e.g., atomicbomb survivors and therapeutically irradiated patients). The effects of internal radiation exposure among workers are less clear. Epidemiological studies have demonstrated that exposure to a number of alpha-particle emitters ( 224 Ra, 226 Ra, and 228 Ra; 232 Th; and aerosols of 239 Pu and its decay products) increases the risk of cancer (IARC 2001) . Experimental animal studies have provided sufficient evidence for the carcinogenicity of isotopes of plutonium. Workers in the nuclear fuel cycle may, however, be exposed to a number of other radionuclides, in particular uranium. At present, little direct evidence is available on the carcinogenicity of uranium isotopes. Despite limiting its evaluation to natural uranium ore dust and 233 U and stating that the evidence for carcinogenicity was no more than limited in experimental animals and inadequate in humans, the International Agency for Research on Cancer (IARC) concluded that "internalized radionuclides that emit alpha-particles are carcinogenic to humans" (IARC 2001) . Applying this conclusion to all uranium isotopes ignores the possibility that the health effects of occupational exposure to uranium may vary depending on exposure conditions and the nature of the uranium compounds. Because of the potential for significant occupational uranium exposures in the nuclear industry, for both the nuclear fuel cycle and the production of nuclear weapons (ICRP 1980; UNSCEAR 2000) , understanding current knowledge about the carcinogenic effects of exposure to uranium isotopes is important.
Numerous stages in the nuclear fuel cycle provide the potential for uranium exposure: mining; milling of uranium; uranium conversion and enrichment; reactor fuel fabrication; reactor operation; nuclear fuel reprocessing; waste handling and disposal; and research and development. The potential for exposure to external gamma radiation is present in each of these stages. The potential for internal radiation exposure varies throughout the process because of the methods used and the chemical characteristics of the uranium present. Milling consists of crushing and grinding raw uranium ore followed by chemical leaching, separation of uranium from the leachate, and precipitation as "yellowcake." Yellowcake, a chemically complex mixture of diuranates, basic uranyl sulphate, and hydrated uranium oxides, contains 70 -90% uranium. Internal exposure may occur through inhalation or ingestion of radionuclides in ore dust. During uranium conversion, U 3 O 8 , the main component of the yellowcake, is reduced to UO 2 using hydrogen, then to UF 4 by addition of hydrofluoric acid, and finally to UF 6 by exposure to fluorine. Gaseous diffusion enriches the UF 6 from 0.7% 235 U to about 3% 235 U. After enrichment, UF 6 is reconverted into UO 2 for fuel fabrication. During these processes, workers may be exposed to internal irradiation by inhalation during maintenance work or processing leaks. During fuel fabrication, exposure results from intake of airborne radionuclides contained in un-enriched uranium metal, un-enriched to slightly enriched UO 2 , or mixed UO 2 -PuO 2 fuel. Fuel reprocessing which involves dissolution of the spent fuel elements in acid, followed by chemical separation of uranium and plutonium from the solution, has the potential for exposure to internal radiation. Internal exposure to uranium isotopes may also occur during the development and production of nuclear weapons, although inhalation or ingestion of plutonium isotopes and skin absorption of 3 H are the primary potential sources of exposure.
In addition to gamma radiation, external exposure to neutrons is also possible. Because of variations in the type and size of airborne uranium particles found throughout the nuclear fuel cycle, the solubility and resulting biokinetic distribution of uranium in the human body differ significantly (Ansoborlo et al. 2002) . Soluble uranium compounds are incorporated through the lungs and transported by the blood to the kidney for excretion. Insoluble uranium, however, is retained in the lung, deposited in tracheobronchial or other thoracic lymph nodes, or swallowed (ICRP 1980; Lang et al. 1995) . Consequently, health hazards are likely to vary across the nuclear fuel cycle because the different forms of uranium are present in each stage.
The aim of this paper is to summarize the epidemiological studies of nuclear workers with potential for internal exposure to uranium published since 1980. The question of specific cancer hazards among these workers and their possible relation with specific activity are addressed.
MATERIALS AND METHODS
The PubMed (http://www.pubmedcentral.nih.gov), Biosis (http://www.biosis.org), Embase (http://www. embase.com), and Energy Science & Technology (http:// www.dialog.com) databases for the period 1980 -2006 were searched to identify all epidemiological studies dealing with health hazards among uranium process workers. The following keywords were used: nuclear workers, uranium, process, nuclear fuel, internal contamination, occupational exposure, intake, epidemiology, risk, mortality, and cancer. References in each paper were reviewed for additional sources. Studies of millers were included, but those of uranium miners were excluded because their exposure is mainly to radon, which is classified as a pulmonary carcinogen by the IARC. Case reports, conference proceedings, editorials, reviews, and ecological studies were also excluded. The examination of the effects of internal exposure focused on the organ systems through which uranium particles pass from intake to excretion. Of primary interest were lung cancer, upper aerodigestive tract cancers, hematoand lymphopoietic malignancies, and urinary tract cancers. Furthermore, the relationship between exposure and cancer risk was examined in studies where internal exposure to uranium was assessed. The limitations of the available literature, especially those inherent in exposure assessment, are discussed.
RESULTS

Epidemiological studies
Twenty-three published epidemiological studies were reviewed in depth: 18 cohort studies (Beral et al. 1985 (Beral et al. , 1988 Dupree et al. 1987; Checkoway et al. 1988; Cragle et al. 1988; Fraser et al. 1993; Loomis and Wolf 1996; Carpenter et al. 1998; Ritz 1999a and b; Baysson et al. 2000; Dupree-Ellis et al. 2000; McGeoghegan and Binks 2000a and b; Ritz et al. 2000; Atkinson et al. 2004; Pinkerton et al. 2004; Boice et al. 2006b) (Tables 1 and 2) and 5 nested case-control studies (Carpenter et al. 1987 Rooney et al. 1993; Dupree et al. 1995; Richardson and Wing 2006) (Table 3) . The cohort studies summarized in Table 1 were sorted by the stage of the nuclear fuel cycle in which workers were employed. Only 1 of the 5 available cohort studies of millers was retained because the other four studies included miners. Eleven of the 18 cohort studies assessed internal exposure to uranium quantitatively, in terms of dose equivalent to the lung (Dupree et al. 1987; Checkoway et al. 1988; Ritz 1999b; Ritz et al. 2000) , whole body , or other organs (Boice et al. 2006b ); qualitatively, as a dichotomised variable exposed/non exposed (Beral et al. 1985 (Beral et al. , 1988 Fraser et al. 1993; Atkinson et al. 2004 ); or as a mixed time-dependent variable combining exposure status with duration of exposure (Carpenter et al. 1998; Baysson et al. 2000) . The relation between internal exposure to uranium and cancer mortality was examined in only 6 cohort studies (Table 2) . Table 3 summarizes the 5 nested case-control studies that investigated the risk of specific cancers with an observed excess in the original cohort studies: brain and central nervous system (CNS) (Carpenter et al. 1987 and lung cancer (Dupree et al. 1995; Richardson and Wing 2006) Ridge and Fernald uranium processing plant workers, and prostate cancer among UK researchers (Rooney et al. 1993) .
Disease outcomes
All studies reported results of mortality analyses [Standardized Mortality Ratio and its 95% confidence interval, SMR (95%CI)]; four of them (Carpenter et al. 1998; McGeoghegan and Binks 2000a and b; Pinkerton et al. 2004 ) also reported analyses of cancer incidence. With one exception (Dupree et al. 1987) , the mortality from all causes and all cancers was not greater than expected when compared to the general population. The SMRs were increased for some site-specific cancers. Fig.  1 presents SMRs and 95% confidence intervals for selected cancer sites.
Respiratory system
An increase in mortality from trachea, bronchus, and lung cancer (ICD-9 162) was reported among uranium milling (Pinkerton et al. 2004 ) and processing workers (Checkoway et al. 1988; Loomis and Wolf 1996) (Fig. 1) . Among a cohort of millers (Pinkerton et al. 2004 ), 78 deaths due to lung cancer were observed. Compared to the U.S. rates since 1940, the SMR was 1.13, ]. This increase was significant and greater when compared to the state rates (Colorado, Arizona, New Mexico and Utah) (SMR ϭ 1.51, 95%CI [1.19 -1.59], n ϭ 75). The increase was significant among men who began work before 1955, when exposures to uranium, silica, and vanadium were presumed to be high. The role of other chemical exposures and of tobacco was not assessed as data were lacking. Hence, this study is rather inconclusive with respect to the association between lung cancer mortality and internal exposure to uranium during milling.
The study of French uranium metallurgy researchers (Baysson et al. 2000) computed the SMR for all respiratory cancers combined (ICD-9 160 -164) (SMR ϭ 1.07, 90%CI [0.56 -1.87], n ϭ 9) rather than only lung cancer. The dose-response relationship between exposure to uranium radionuclides was estimated only for all cancer mortality (Table 2) . At Rocketdyne, dedicated to fabricating nuclear fuel, disassembling and decontaminating reactor facilities, decladding spent nuclear fuel, and storing nuclear materials, lung cancer risk was not increased among workers included in the study by Ritz et al. (2000) -12 1947−1979 6,781 (862/196) 1947−1979 6,781 (3,490/5,278) Poisson regression Lung Not monotonically increase of RR with IE in 0 year lag model -involved in nuclear fuel assembly and disassembly operations who were monitored for internal radionuclide exposure. More than 95% of the estimated internal cumulative dose to the lung was from uranium and mixed-fission products. Compared to the 0 mSv dose category, lung cancer risk was not increased in any internal dose categories (Ͼ0 -4.9, 5-29.9, ϩ30 mSv), and no trend was observed in 0, 2, or 10-y lag analyses. The study (Boice et al. 2006b ) using different inclusion criteria and exposure assessment approach provided similar results. Dose response analyses were based on cumulative organ doses derived from external (photon and neutron) and internal radiation monitoring data. Annual internal doses from 14 different radionuclides were estimated for 2,232 workers monitored for internal radiation exposure (Boice et al. 2006b (Boice et al. 2006b ). Since internal doses were estimated from intake of 14 different radionuclides, the role of the internal exposure to uranium was not elucidated in this study. Among workers at the Y-12 facility in Tennessee where uranium was processed into UF 4 and uranium metal for weapons, a significant excess of lung cancer risk was observed, first by Checkoway et al. (1988) (SMR ϭ 1.36 [1.09 -1.67], n ϭ 89), and later by Loomis and Wolf (1996) (SMR ϭ 1.17 [1.01-1.34], n ϭ 202). In both studies, it was exclusively among men hired before 1955 during intensive weapons production. Checkoway et al. (1988) performed dose response analyses for both external and internal radiation. In the model with a 0-y lag, the trend with cumulative lung dose did not increase monotonically. The RR was 1.52 ([0.53-4 .38], n ϭ 11) for internal doses Ն10 to 49 mSv, 2.48 ([0.87-7 .08], n ϭ 12) for doses Ͼ50 to 99 mSv, and 1.87 ([0.68 -5.20] , n ϭ 17) for doses Ն100 mSv compared to the referent exposure limit (Ͻ10 mSv). In the 10-y lag model, the dose-response trend was considerably reduced. The authors concluded that there was no indication of a positive dose-response relation with internal exposure to uranium.
A nested case-control study of a cohort of Y-12 workers was recently performed by Richardson and Wing (2006) and confirmed the preceding conclusion. The cohort included 3,864 white male workers who were hired at the Y-12 after 1946, and had no indication of employment at any other Department of Energy nuclear facility. The association between external and internal radiation dose and lung cancer mortality was examined (Table 3) . Mean cumulative internal radiation dose was 44.7 mSv. Although the risk was increased in all categories of cumulative internal dose (10 -49.9, 50 -99.9, Ն100 mSv) compared to the (Ͻ10 mSv) reference category, no trend was observed. Logistic regression analysis showed a negative dose-response relationship between internal dose and lung cancer mortality. Negative associations were also observed between internal dose and time since exposure and age at exposure. A case-control study by Dupree et al. (1995) examined the relation between lung cancer risk and uranium dust exposure in four uranium processing facilities: Tennessee Eastman Corporation (TEC), Y-12 plant, Mallincrodt Chemical Works' Uranium Division (MCW) and Fernald Feed Materials Production Center (FFMPC). Odds ratios (OR) for lung cancer mortality for seven cumulative internal dose groups did not show increasing risk with increasing exposure. The OR was increased only for workers exposed to 25 cGy and higher, but not significantly (2.05 [0.20 -20 .0], n ϭ 2). Analyses for cumulative external dose from exposure to thorium, radium, and radon did not reveal any consistent association between exposure and increased risk, nor did dichotomizing workers by facility. Ritz (1999b) estimated the effect of internal radiation on the respiratory cancer mortality in an update of the FFMPC cohort. Respiratory cancer risk was increased only among workers with internal doses exceeding 200 mSv, compared to those exposed to less than 10 mSv. Lagging the dose 15 years increased the risk (RR ϭ 1.92 [0.53-6.96]) compared to no lag (RR ϭ 1.18 [0.32-4.41]) but was based on three lung cancer cases. In summary, the evidence currently available appears to support an absence of positive association between the internal exposure to uranium compounds and mortality from lung cancer.
Results available for laryngeal cancer are more definitive. Among MCW workers involved in processing uranium ore to UF 4 and UO 3 , mortality from laryngeal cancer was significantly increased compared to the U.S. and two counties surrounding the plant (4.47 [1. 44 -10.43] and 3.57 [1.21-8.63] , n ϭ 5) (Dupree et al. 1987) . These deaths occurred in the sixth decade of life and 14 -25 y after their first hire. Three men worked during the period when exposure to internal radiation and some chemicals were likely high, although these exposures were not estimated. Moreover, elevated alcohol and tobacco consumption was reported based on the workers' occupational medical records. Therefore we cannot attribute the excess in laryngeal cancer to the uranium internal exposure. Among workers monitored for radiation exposure (x and gamma rays, neutrons, and beta particles) at the UK Atomic Weapons Establishment (UK AWE), mortality from laryngeal cancer was also increased compared to national rates but not different compared to mortality of unmonitored workers (RR ϭ 0.91 [0.21-3.96]) (Beral et al. 1988 ). The authors did not report if workers actually received any internal exposure. Among workers at Rocketdyne, Ritz et al. (2000) found 4 deaths due to cancer of the larynx (SMR ϭ 1.99 [0.54 -5.11]). Internal comparisons of monitored workers with a cumulative dose Ͼ30 mSv with those who received 0 mSv produced a rate ratio for upper aerodigestive cancers of 57.2 [8.17-401] based on 2 deaths with a positive dose-response relationship (Table 2 ). In an analysis by Boice et al. (2006b) the laryngeal cancer SMR was 1.63 [0.75-3.09] based on 9 deaths. For the subset of 2,232 workers who were monitored for internal radiation, the laryngeal cancer increase was of borderline significance (2.74 [1.01-5.96], n ϭ 6). Boice et al. did not perform a dose-response analysis for either laryngeal cancer or upper aerodigestive cancers. Although the evidence to support a dose-response relationship is limited to one study, the results of the four studies suggest an increased risk of laryngeal cancer with exposure to internal radiation.
Excess mortality from pleural cancer was noted (SMR ϭ 4.96, p ϭ 0.009, n ϭ 5) among radiation workers at Capenhurst where uranium was enriched for fuel production and defense purposes (McGeoghegan and Binks 2000a). All observed cases were mesotheliomas. Similar results were observed within the UK nuclear industry dedicated to research and development of nuclear energy and atomic weapons (Carpenter et al. 1994 (Carpenter et al. , 1998 . Exposure to asbestos was strongly related to risk of mesothelioma (McGeoghegan and Binks 2000a) with no association between pleural cancer and internal radiation exposure found. Fig. 2 summarizes the study results for leukemia, Hodgkin's disease, and other lymphatic and haematopoietic tissue cancer.
Lymphatic and haematopoietic tissue
Among millers (Pinkerton et al. 2004 ), a nonsignificant increase in mortality from lymphatic and haematopoietic malignancies other then leukemia was observed (1.44 [0.83-2.35] , n ϭ 16) compared to the U.S. 1940 -1998 mortality rates. This excess was due to mortality from lymphosarcoma and reticulosarcoma (1.74 [0.48 -4.46] , n ϭ 4) and Hodgkin's disease (3.30 [0.90 -8.43 ], n ϭ 4). Compared to the U.S. 1960 -1998 rates, mortality from non-Hodgkin's lymphoma (1.25 [0.54 -2.46], n ϭ 8) and Hodgkin's disease (4.01 [1.09 -10.25], n ϭ 4) was also elevated. The excess in mortality from Hodgkin's disease was confined to workers whose first employment was at least 20 years earlier. However, an association between these outcomes and exposure to uranium cannot be evaluated since the exposure was not assessed.
Among uranium processing workers, an increase in mortality from lymphatic and haematopoietic malignancies was reported in all cohorts except the Linde cohort (Dupree et al. 1987) . Among MCW employees (Dupree-Ellis et al. 2000) , increases in SMRs for multiple myeloma , n ϭ 5) and leukemia (1.11 [0.57-1.89], n ϭ 11) were observed compared to the U.S. male population. At FFMPC (Ritz 1999b) , an increased SMR for lymphopoietic cancer was of borderline significance (1.29 [0.91-1.77], n ϭ 38) with the greatest SMRs reported for Hodgkin's disease (2.04 [0.74 -4.43], n ϭ 6) and lymphosarcoma and reticulosarcoma (1.67 [0.72-3.29] , n ϭ 8). Although no dose-response relationship was found between internal radiation and lymphatic and hematopoietic malignancies, protracted exposure (Ͼ5 y) increased risk of lymphatic and haematopoietic cancer (RR ϭ 1. 85 [0.87-3.95] , n ϭ 15) after adjustment for trichloroethylene (TCE) exposure. At Y-12, Checkoway et al. (1988) reported an increased SMR for other lymphatic cancers 203, 208; , n ϭ 9) compared to U.S. white males, and for multiple myeloma , n ϭ 4), compared to Tennessee white males. Loomis and Wolf (1996) confirmed these Loomis and Wolf (1996) addressed the dose-response relationship between internal radiation exposure and multiple myeloma or hemato-lymphopoietic malignancies. Among employees of the British Nuclear Fuels Limited (BNFL) Springfield site (McGeoghegan and Binks 2000b), Hodgkin's disease mortality was increased compared to the mortality of the population of England and Wales (SMR ϭ 1.25, 12 deaths) and the surrounding area of Lancashire (SMR ϭ 1.57) for the period 1979 -1992. Increased morbidity from Hodgkin's disease was also noted (SRR ϭ 1.22, n ϭ 12). While workers for whom external whole body radiation data were available experienced higher morbidity from Hodgkin's disease than workers without such data (SRR ϭ 1.39, n ϭ 10), internal exposure to uranium was not specifically addressed in this study. Among nuclear fuel fabrication and reprocessing workers, an excess of leukemia was also observed. At Rocketdyne, Ritz et al. (2000) reported a leukemia SMR of 1.46 ([0.63-2.88], n ϭ 8) although mortality from all lymphatic and haematopoietic cancer was comparable with the U.S. population (SMR ϭ 0.83 [0.43-1.45], n ϭ 12). Internal comparison of workers with an internal radiation cumulative dose Ͼ30 mSv to those with 0 mSv produced a rate ratio of 44.6 [5.64 -353] based on 3 cases of lymphatic and haematopoietic cancer and a statistically significant positive doseresponse trend. In the analysis by Boice et al. (2006b) , the number of observed deaths from leukemia was greater (n ϭ 25) but the SMR was slightly less than in the previous study (1.33 [0.86 -1.97]). The SMR for chronic lymphocytic leukemia (CLL, ICD-9 204.1; 2.04 [0.82-4.21], n ϭ 7) was higher than for other leukemia (1.16 [0.69 -1.84], n ϭ 18), especially among workers monitored for internal radiation (3.03 [0.83-7.76], n ϭ 4). The SMR for Hodgkin's disease was also increased (1.99 [0.65-4.63], n ϭ 5). In the dose-response analysis, a monotonic association between cumulative radiation exposure and mortality from lymphatic and haematopoietic malignancy was observed. However, organ-specific radiation doses used in dose-response analyses included external radiation dose, known to be carcinogenic for the lymphatic and haematopoietic malignancy. Hence this study could not confirm a positive relation of the internal exposure and lymphatic and haematopoietic cancer. Among Savannah River Plant (SRP) hourly workers, leukemia mortality (SMR ϭ 1.63, n ϭ 13) was elevated compared to the U.S. population, though not significantly ). An increase in leukemia mortality was significant among workers who had been hired before 1955 and worked between 5 and 15 y (2.75 [1.01-5.99], n ϭ 6). While a dose-response analysis was not done, internal radiation doses were assessed for all 14 leukemia cases. Six cases had some internal radiation exposure while employed at the SRP, including exposure to natural uranium, fission products, plutonium, and enriched uranium; but none exceeded the current occupational radiation limit. The mean cumulative dose equivalent was 46.75 mSv. Capenhurst workers involved in uranium enrichment, uranium metal processing, and weapons production had a significant deficit of mortality from all leukemia excluding CLL (McGeoghegan and Binks 2000a) . However, Hodgkin's disease mortality was higher than expected (SMR ϭ 126, n ϭ 9). In the UK Atomic Energy Authority (UK AEA) study by Beral et al. (1985) , mortality from all lymphatic and haematopoietic malignancies was increased among women who were not monitored for radiation exposure (SMR ϭ 136, n ϭ 15). This increase was mainly due to deaths from Hodgkin's disease (SMR ϭ 177, n ϭ 3) and leukemia (SMR ϭ 160, n ϭ 7). Non-Hodgkin's lymphoma mortality was slightly increased among men monitored for radiation exposure (SMR ϭ 121, n ϭ 12). Information on radiation exposure was based on personal radiation records and included only estimated whole body radiation doses. Evaluation of internal exposure was limited to noting years in which workers were monitored for possible radionuclide contamination including uranium isotopes.
The leukemia SMR increased with employment duration in employees monitored for radiation exposure, whereas the trend was in the opposite direction in those not monitored. Workers who were not monitored for radiation exposure and stayed with UK AEA for less than 2 y had a mortality excess from leukemia (SMR ϭ 234 ). In an updated analysis by Atkinson et al. (2004) , an increase in Hodgkin's disease mortality , n ϭ 7) was observed in women. An increase in leukemia mortality was also observed in women , n ϭ 22) and all workers combined , n ϭ 103). The increase in leukemia , n ϭ 62) and non-Hodgkin's lymphoma , n ϭ 53) mortality was confined to workers monitored for external radiation exposure. No excess was found among workers monitored for internal radiation exposure. Internal radiation exposure was not addressed quantitatively. Baysson et al. (2000) found a significant excess of multiple myeloma (SMR ϭ 838, 90%CI [144 -2620] ) among research workers but the excess was based on two deaths, insufficient for a separate dose response analysis. In summary, despite numerous studies that reported an increase in mortality from hemato-and lymphopoietic malignancies, only three studies estimated the effects of internal radiation exposure from uranium (Ritz 1999b; Ritz et al. 2000; Boice et al. 2006b ), and only Ritz et al. (2000) found a significantly positive association.
Digestive system
Generally, mortality due to digestive system cancers was lower than expected compared to the national population. Nonsignificant increases were observed among uranium processing workers involved in the conversion of uranium (Dupree et al. 1987) (SMR ϭ 131 [86 -190] , n ϭ 27) and the production of uranium metal (Ritz 1999a and b) , n ϭ 87). Mortality from some site-specific digestive cancer was increased but never significantly.
For esophageal cancer, a nonsignificant 30% mortality increase was reported among uranium processing workers ( Fig. 1) (Dupree-Ellis et al. 2000) without addressing the role of internal exposure to uranium radionuclides. Among workers who were monitored for internal radiation at Rocketdyne mortality was also increased (Ritz et al. 2000; Boice et al. 2006b ). In dose-response analyses of internal radiation exposure, Ritz et al. (2000) found a significant positive association for cancer of the upper aerodigestive tract (see results for laryngeal cancer) which included esophagus and stomach cancer. Boice et al. (2006b) did not estimate the effect of cumulative radiation exposure on esophagus cancer mortality.
An increased SMR for stomach cancer mortality was observed among uranium conversion (Dupree et al. 1987) (165 [66 -339] , n ϭ 7), and uranium metal production workers (Ritz 1999b) (134 [75-221] , n ϭ 15). The risk of stomach cancer was higher among uranium metal production workers exposed to trichloroethylene (TCE) for at least two years (RR ϭ 2.21 [0.91-5.30], n ϭ 15) (Ritz 1999a) . Boice et al. (2006b) also found an increased SMR for stomach cancer among workers with internal radiation dose (170 [88 -297] , n ϭ 12), but the dose-response analysis lagging cumulative radiation dose 10 years did not show a significant trend.
Colorectal cancer mortality was elevated among uranium conversion workers (Dupree-Ellis et al. 2000) (rectal cancer SMR ϭ 148, n ϭ 9; colon cancer SMR ϭ 111, n ϭ 27) and fuel processing workers (McGeoghegan and Binks 2000b) (SMR ϭ 118, n ϭ 14), (Boice et al. 2006b) (135 [89 -197] , n ϭ 26). Among nuclear research workers mortality from cancer of the small intestine was slightly increased among radiation workers (SMR ϭ 143, n ϭ 3) (Fraser et al. 1993 ) and among non-radiation workers (SMR ϭ 119, n ϭ 24) (Beral et al. 1985) . This excess was significant in workers with a duration of employment from 2 to 10 years (SMR ϭ 174, n ϭ 21) (Beral et al. 1985) . Ritz (1999b) found no effect of cumulative internal exposure to uranium compounds on the lower gastrointestinal tract cancers (35 cases). Boice et al. (2006b) noted a nonsignificant decreasing trend between cumulative radiation exposure and mortality from colorectal cancer.
Mortality due to liver cancer was low in comparison with the national mortality rates except for two cohorts of workers (Ritz 1999b; McGeoghegan and Binks 2000b) . The SMR for the FFMPC workers was 130 ([70 -320] , n ϭ 8) and for the Springfield workers was 118 (22 deaths, all radiation workers). The risk of liver cancer death increased in FFMPC workers with light exposure to kerosene and moderate exposure to TCE. Lagging exposure by 15 y, the risk was significant but based on only 1 death. (Ritz 1999a) . The relationship of internal exposure to uranium compounds and liver cancer mortality was not investigated.
Pancreatic cancer mortality was increased at least 20% above U.S. male mortality in two cohorts of workers involved in uranium conversion (Ritz 1999b; Dupree-Ellis et al. 2000) . At the Y-12 plant dedicated to uranium conversion and recycling, the SMR was even greater (135 [94 -190] , n ϭ 34) (Loomis and Wolf 1996) .
Urinary system
Among uranium millers, mortality from kidney cancer was lower than in the U.S. population (SMR ϭ 81 , n ϭ 4) (Pinkerton et al. 2004 ). Looking at uranium conversion, a nonsignificant increase in kidney cancer mortality was observed only at the MCW facility (1.17 [0.54 -2.18], n ϭ 8) (Dupree-Ellis et al. 2000) . Dose-response analyses using dose equivalent from beta and gamma radiation produced a positive association for kidney cancer. Potentially high external radiation exposure occurred during pitchblende processing operations, which were done manually. Although internal radiation or chemical exposures were not considered in the analysis, internal radiation exposure or chemical toxicity from high uranium and silica dust concentrations were also high during pitchblende processing. Seven workers who died from kidney cancer worked in the pitchblende processing. Similarly, a nonsignificant increase in kidney cancer mortality was reported for the Rocketdyne fuel fabrication and reprocessing workers (Ritz et al. 2000; Boice et al. 2006b ). In the cohort evaluated by Boice et al. (2006b) , a nonsignificant increasing trend was reported between kidney cancer mortality and cumulative radiation dose. Looking at the production of fuel and other nuclear materials for defense purposes, kidney cancer mortality was increased at two facilities: Y-12 (Checkoway et al. 1988; Loomis and Wolf 1996) and the Capenhurst site (McGeoghegan and Binks 2000a) . But at Capenhurst the increase was limited to non-radiation workers. Nuclear research workers at UK AWE (Beral et al. 1988; Carpenter et al. 1998 ) also experienced elevated mortality from kidney cancer. However, none of these studies included an investigation of the relation with internal exposure to uranium.
An increase in bladder cancer mortality was confined to two cohorts: uranium conversion workers at the MCW (Dupree-Ellis et al. 2000) and metal production workers at the FFMPC (Ritz 1999b) . Bladder cancer risk was significantly associated with a heavy exposure to cutting fluids used during uranium metal production (Ritz 1999a) . No association with internal exposure to uranium compounds was observed with either a 0-y lag or a 10-y lag (Ritz 1999b ).
Other sites
Bone cancer cases were not observed among uranium milling or processing workers except for one case found among the MCW workers (SMR ϭ 120 ) (Dupree-Ellis et al. 2000) . Among workers involved in the production of fuel and other nuclear materials, mortality from bone cancer was less than the national population with only 1 or 2 deaths observed (McGeoghegan and Binks 2000a; Cragle et al. 1988; Loomis and Wolf 1996; McGeoghegan and Binks 2000b ). An identical pattern was observed among nuclear research workers (Beral et al. 1985 (Beral et al. , 1988 Fraser et al. 1993; Carpenter et al. 1998) .
Brain and central nervous system (CNS) cancer mortality was of borderline excess in the Y-12 cohort (SMR ϭ 180, n ϭ 14) (Checkoway et al. 1988 ). However, this finding was not confirmed in a subsequent analysis (Loomis and Wolf 1996) , n ϭ 20) (Fig. 1) . When Checkoway et al. investigated brain and CNS cancer mortality with respect to internal radiation exposure using cumulated lung dose equivalent, no dose-response trends were found. At Rocketdyne, mortality from brain cancer was lower in the Boice et al. (2006b) study (SMR ϭ 84) than in the Ritz et al. (2000) study (SMR ϭ 131). Brain cancer mortality at the FFMPC was nonsignificantly increased among workers with moderate exposure to cutting fluids (Ritz 1999a) . Carpenter et al. (1987) (Table 3 ) investigated the possible association between brain and CNS cancers and exposure to external and internal radiation among Y-12 workers. Like Checkoway et al. (1988) , instead of the brain dose, annual lung dose was a surrogate for brain dose for 47 cases and 120 matched controls. Air monitoring samples were used to estimate dose from 1943 and 1947 when uranium was enriched to a high degree, and urinalyses and whole body counts were used after 1947. ORs were elevated for categories of cumulative lung dose Ն150 to 290 mSv (2.8 [0.7-11.9] , 5 cases/6 controls), Ն 300 to 450 mSv (2.7 [0.8 -9 .3], 5/6) and the highest (Ͼ150 mSv) average annual lung dose category (1.7 [0.7-4.2], 16/33) . No dose-response trend was observed after adjustment for possible confounding (26 different chemicals, socioeconomic status, duration of employment) and 5 or 10-y lagging.
Prostate cancer mortality was increased in almost all portions of the nuclear cycle except for fuel fabrication (McGeoghegan and Binks 2000a) and reprocessing activities (Ritz et al. 2000; Boice et al. 2006b ). However, there is no evidence of a relation between uranium radionuclide intake and prostate cancer mortality because the exposure to uranium was insufficiently estimated. Excess in prostate cancer mortality was significant in UK AEA workers monitored for contamination by tritium and other unspecified radionuclides (containing uranium) (Beral et al. 1985) . However, exposure to internal radiation was not estimated quantitatively. In the most recent study (Atkinson et al. 2004) , the association of prostate cancer with radiation exposure in workers monitored for internal contamination was much less strong (p ϭ 0.06), and the trend was confined to the period 1946 -1979. In the combined analysis of three UK nuclear industry workforces (Carpenter et al. 1998 ) internal radiation dose was not estimated. Mortality from prostate cancer was elevated in workers monitored for exposure to radionuclides compared with the population of England and Wales (SMR ϭ 153, p Յ 0.05) and with an internal comparison (RR ϭ 1.65 [1.03-2.65]). The risk was significantly higher among workers first monitored before age 35 y and before 1960. Rooney et al. (1993) investigated the relation between prostate cancer and occupational exposure in UK AEA employees. A total of 404 controls were matched to 136 cases diagnosed between 1946 and 1986. Among the 29 assessed radionuclides were 238 U, 235 U, and 233 U. Looking at uranium radionuclide intake, only 3 cases and 12 controls were contaminated and no effect on prostate cancer mortality was observed. Among uranium processing workers, an increase in prostate cancer mortality was often observed but never significant: , n ϭ 32) (Dupree-Ellis et al. 2000) , , n ϭ 25) (Ritz 1999b) , , n ϭ 36) (Loomis and Wolf 1996) , and (SMR ϭ 135, n ϭ 5) .
Female reproductive cancer mortality results are limited and must be interpreted with caution because few studies included female workers. With quantitative data on internal exposure to uranium compounds unavailable for most studies, risk analyses were limited to internal comparisons between radiation or workers monitored for radionuclide exposure and non-radiation workers. Increased uterine and ovarian cancer mortality was reported for female radiation workers in UK AEA nuclear research activities (SMR ϭ 189, n ϭ 9) (Beral et al. 1985) . Uterine cancer risk was in excess among UK AEA women monitored for radionuclides in the Fraser et al. (1993) study , n ϭ 2) and confirmed in the study by Atkinson et al. (2004) , n ϭ 4). In the study of 3 UK nuclear facilities (Carpenter et al. 1998) , uterine cancer mortality was elevated in women monitored for radionuclide exposure compared with the England and Wales populations (SMR ϭ 432, n ϭ 3) and with workers not monitored for internal exposure (RR ϭ 7.28 [1.10 -47.81]). In contrast, a significant excess of uterine cancer mortality was found among women not exposed to ionizing radiation (SMR ϭ 1.96, n ϭ 13) at the Springfield facility compared with the England and Wales population (McGeoghegan and Binks 2000b) .
DISCUSSION
Completeness of bibliographical research
From 23 studies identified as relevant for this review of cancer mortality among nuclear workers with potential of internal exposure to uranium, studies of workers in only 3 countries were found; 11 investigated American nuclear facilities, 8 were based on the UK nuclear workforce, and 1 included French uranium metallurgy research workers. Many other countries have nuclear fuel cycle workers. According to UNSCEAR (2000) , uranium is converted and enriched in Canada, France, Japan, The Netherlands, and South Africa. Fuel is produced in Argentina, China, Russia, Spain, and Sweden and reprocessed in India, Japan, and France. Nuclear fuel cycle research is active in more than 20 different countries. Further searching of the literature identified a number of studies of nuclear workers, especially Canadian (Gribbin et al. 1993; Sont 1994; Zielinski et al. 1997; Ashmore et al. 1998; Sont et al. 2001; Zablotska et al. 2004) and European (Gulis 2003; Telle-Lamberton et al. 2004; Engels et al. 2005; Rogel et al. 2005 ) studies. However, these studies only evaluated the relationship between disease outcomes and external radiation exposure with no analysis of internal radiation dose. The possible explanation for this lack of inclusion of internal radiation exposure is the poor historical data available for its assessment and the great complexity and numerous uncertainties surrounding internal dose estimation. Moreover, dosimetry data are primarily collected to demonstrate compliance with radiation protection regulations, not for the purpose of epidemiological research. These difficulties limit epidemiological investigations.
CONCLUSION
Our review shows that in several cohorts of workers with potential occupational exposure to uranium, cancer mortality risk was increased nonsignificantly. Among 18 cohorts, few studies presented a significant excess in mortality from cancer of a priori suspected sites, such as lung (Checkoway et al. 1988; Loomis and Wolf 1996) , larynx (Ritz 1999b; Ritz et al. 2000) , or lymphatic and haematopoietic tissue Pinkerton et al. 2004) . Statistically significant dose-response relationships with internal radiation dose from uranium exposure were reported for only two cancer sites: lymphatic and hematopoietic tissues and upper aerodigestive tract (Ritz et al. 2000) . Hence, the epidemiological evidence currently available remains limited. Increases in mortality from respiratory and lymphatic and hematopoietic cancers are consistent with the evidence from the study of uranium distribution in humans, especially after intake of insoluble uranium particles (Russell and Kathren 2004) . Facilities where excess respiratory cancer was found have reported handling mainly insoluble uranium compounds (Table 1) . Experimental animal studies show that chronic low dose exposure to insoluble uranium oxides and uranium ore dusts induce cell proliferation (carcinoma and adenomas) and fibrosis and/or necrosis in the lung parenchyma (Leach et al. 1970 (Leach et al. , 1973 Mitchel et al. 1999) . Lung response to low-solubility particles may be due to the recruitment, activation, and subsequent release of damaging mediators by the inflammatory cells (Driscoll et al. 1996 (Driscoll et al. , 1997 . Chronic inflammatory response implicates growth factors and cytokines which may be involved with interstitial pulmonary fibrosis (Martin et al. 1998; Lasky and Brody 2000; Albrecht et al. 2004 ) and carcinogenic processes (Shacter and Weitzman 2002; Ohshima et al. 2003) . DNA damage and chromosomal aberrations were found in peripheral blood lymphocytes and leukocytes of workers occupationally exposed to uranium compounds and low dose ionizing radiation (Prabhavathi et al. 1995 (Prabhavathi et al. , 2000 Touil et al. 2002; Garaj-Vrhovac and Kopjar 2003; Kopjar and Garaj-Vrhovac 2005; Garaj-Vrhovac et al. 2006) . Chromosomal aberrations were also found in miners exposed to uranium (Popp et al. 2000; Meszaros et al. 2004) .
Mortality from cancers of the kidney, bladder, and esophagus were raised but not significantly, although chronic renal diseases were observed in significant excess (Dupree-Ellis et al. 2000; Pinkerton et al. 2004 ). Kidney and skeleton have long been considered the primary sites of uranium accumulation (Kathren and Moore 1986; Singh et al. 1987; Kathren et al. 1989; Kurttio et al. 2005) . But, presently, the United States Transuranium and Uranium Registries stipulate that "the ICRP Reference value for uranium in kidney is too high and should be reduced by at least a factor of 10" (Russell and Kathren 2004) . Chemical toxicity of uranium in the kidney was confirmed for acute exposure with the development of the renal failure and histological lesions characteristic of uranium nephropathy (Leggett 1989; Taulan et al. 2004 Taulan et al. , 2006 . However, recent investigations of renal effects resulting from chronic uranium ingestion did not show any renal damage (Kurttio et al. 2002 (Kurttio et al. , 2006 .
In the light of these experimental observations, it appears important to survey not only mortality but also morbidity among workers with a potential of uranium compound intake. Results from studies reviewed in this paper provide limited evidence of a relationship between site-specific cancer mortality and internal radiation dose resulting from uranium exposure.
Main limitations of currently available literature
Inconsistency in the results between internal exposure to uranium and cancer risk reflects three main limitations common to almost all studies: limited statistical power, relatively low radiation doses, and inaccurate exposure assessment. The problem of statistical power affects most of the nuclear workers cohorts. With the exception of the UK combined study (Carpenter et al. 1998) , the cohort studies included less than 5,000 workers monitored for internal contamination. Despite a long period of follow up (on average 42 y), the number of deaths tended to be small, ranging from 10 to 25% of the cohort. In studies that estimated internal radiation doses for dose-response analyses, statistical power was limited by the relatively low dose levels. For instance, in studies that used a cumulative internal dose to the lung (Checkoway et al. 1988; Dupree et al. 1995; Ritz 1999b; Ritz et al. 2000; Richardson and Wing 2006) , lung cancer risk was raised for dose categories from 10 -30 mSv and more. Since few deaths occurred in the high dose categories, the risk increase did not reach statistical significance and a clear trend was not apparent. Boice et al. (2006a) summarized this issue for the external radiation studies of nuclear workers. A radiation exposure association for any cancer site was only shown in studies that included relatively high dose levels as in the combined country studies (Cardis et al. 1995 (Cardis et al. , 2005 , and studies of the Sellafield and Mayak (Koshurnikova et al. 1996; Shilnikova et al. 2003) facilities.
Comparing internal radiation doses between studies is difficult due to differences in definitions of internally exposed workers. For example, in some cases, only workers with measurable doses are included while in others all monitored workers are included regardless of measurable dose, which affects the average dose of the workforce. Variations in the method used to measure radiation exposure between studies affect the precision of dose estimation. The most accurate assessment of organ or body burden can be made when an incident of internal contamination is known to have occurred, and measurements are made in vitro and in vivo over time. However, in most of the reviewed studies, data were generated from routine monitoring (often annual) and the precise time of intake was unknown. Moreover, these data were often either incomplete (in vivo or in vitro uranium measurements data vs. data on personal or area air sampling) or unavailable so that accurate estimation of the specific organ dose from internal radiation exposure is not possible. Only 4 of the 18 selected cohorts (Table 2) performed dose-response analyses based on estimated internal dose. Assessment of exposure to other products such as solvents, asbestos, silica, hydrocarbures, some heavy metals, etc., known for their carcinogenic or toxic effects, was rarely performed (Table 1) in spite of their potential for confounding.
Effects of the uranium exposure according to the stages of the nuclear cycle
Since most of studies did not assess the exposure to uranium compounds and risk of intake of uranium particles, we tried to report results on cancer mortality according to the stages of the nuclear cycle. Our aim was to discriminate between exposure to soluble and insoluble uranium compounds and to other alpha emitters while looking at the specific effect on cancer mortality patterns. Splitting the worker studies by the stage of the nuclear cycle delimits homogeneous exposure situations and facilitates consideration of additional exposures such as chemicals, silica, asbestos, etc. However, in the present work, too few studies exist in specific stages of the fuel cycle because several studies pooled workers from multiple stages; hence, we could not derive any additional conclusion from this method. Nevertheless, such an approach would be appropriate for a large multiple-country meta-analysis.
Future directions
Although a substantial body of epidemiologic literature on nuclear workers exists, few studies elucidated effects of occupational exposure to uranium compounds, and information on the precise effects of internal deposition of alpha particles from uranium was very limited. With a comprehensive reconstruction of past exposure difficult because of lack of individual monitoring data, there is a need for prospective studies, based on medical follow-up methods presently in use. Epidemiological investigations of uranium workers from countries other than the United States and the United Kingdom are encouraged because few studies have been published. It is also important to conduct a large multi-centric study with a common protocol for estimating internal radiation exposure and its effects and to address the issue of potential confounders.
